drugset / Trial / NCT03936569

A Clinical Study to Assess the Plaque and Gingivitis Effects of a Stannous Fluoride Dentifrice

NCT03936569

Phase 4 Completed 90 enrolled Procter and Gamble
RandomizedParallel-groupDouble-blindTreatment

Summary

The objective of this clinical study is to assess the effects of a 0.454% stannous fluoride dentifrice on gingivitis and plaque after 3 months when compared to a negative control.

Timeline

Start
2018-10-29
Primary completion
2019-01-25
Completion
2019-01-25

Drugs

EvaluationDrugModalityDoseRoute
Comparator sodium monofluorophosphate Unknown 0.76 % Topical
Subject stannous fluoride Small molecule 0.454 % Topical

Indications